Table 3.
Code LB | Sex | Age (Y) | Location | ctDNA | FA | Lesion | T category, AJCC classification | FU | Rx |
---|---|---|---|---|---|---|---|---|---|
21 | F | 70 | Choroid | 4.3 | 9.5 | 3 × 10 × 9 | 2 | 77 | P |
22 | F | 60 | Choroid | 2.8 | 3.7 | 9 × 1.9 × 5.7 | 4 | 50 | P |
27 | F | 68 | Choroid | 3.0 | 8 | 9.7 × 9 × 3.3 | 2 | 39 | P+ |
28 | F | 48 | Choroid | 1.9 | 2.8 | 7.5 × 5.5 × 2.1 | 1 | 260 | TT |
29 | M | 62 | Iris | 12.8 | 2.7 | 3.4 × 3.8 × 1.3 | 1 | 37 | PR |
30 | M | 69 | Choroid | 2.3 | 17 | 16 × 16 × 8 | 3 | 61 | P+ |
31 | M | 85 | Choroid | 29.3 | 33 | 9.5 × 8.5 × 3.1 | 3 | 229 | P |
32 | M | 63 | Choroid | 2.1 | 2.6 | 11.5 × 12 × 2.8 | 1 | 190 | P+ |
33 | F | 82 | Choroid | 26.4 | 7 | 2.2 × 1 × 1 | 2 | 37 | P+ |
36 | M | 37 | Choroid | 31.6 | 3.1 | 13.3 × 10.9 × 5 | 2 | 1 | P |
40 | F | 38 | Choroid | 3.2 | 1.6 | 10.7 × 8.5 × 3.0 | 1 | 92 | SR |
41 | M | 71 | Choroid | 9.8 | 13.5 | 8.2 × 8.7 × 4.3 | 2 | 164 | P |
42 | F | 38 | Choroid | 0.7 | 4 | 13 × 9.5 × 2.3 | 2 | 55 | P+ |
43 | M | 51 | Choroid | 9.0 | 5 | 8.4 × 9.1 × 2.8 | 1 | 150 | P |
+ = anti-VEGF treatment; AJCC AJCC classification; ctDNA (molecules/ml); FA percentage of fractional abundance; FU follow-up time (months); Lesion Lesion size (small diameter x large diameter x thickness) (in mm); P Plaque radiotherapy; PR Proton beam radiotherapy; Rx Treatment; SR Stereotactic radiosurgery; T T category; TT Transpupillary thermotherapy